Evidence map›Paper›PMID 32750315›Full record

ArticleAmerican journal of human genetics2020

Evolution of a Human-Specific Tandem Repeat Associated with ALS.

Meredith M Course, Kathryn Gudsnuk, Samuel N Smukowski, Kosuke Winston, Nitin Desai, Jay P Ross, Arvis Sulovari, Cynthia V Bourassa, Dan Spiegelman, Julien Couthouis and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Structure of a polymorphic repeat at theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Structure of a polymorphic repeat at themedRxiv : the preprint server for health sciences · 2025
    Article
  9. Article
  10. Drug repurposing in amyotrophic lateral sclerosis (ALS).Expert opinion on drug discovery · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Meredith M CourseDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Kathryn GudsnukDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Samuel N SmukowskiDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Kosuke WinstonDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Nitin DesaiDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Jay P RossMontreal Neurological Institute and Hospital, McGill University, Montreal, QC H3A 2B4, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.
Arvis SulovariDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Cynthia V BourassaMontreal Neurological Institute and Hospital, McGill University, Montreal, QC H3A 2B4, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 2B4, Canada.
Dan SpiegelmanMontreal Neurological Institute and Hospital, McGill University, Montreal, QC H3A 2B4, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 2B4, Canada.
Julien CouthouisDepartment of Genetics, Stanford University, Stanford, CA 94305, USA.
Chang-En YuGeriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA 98108, USA.
Debby W TsuangGeriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA 98108, USA.
Suman JayadevDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Neurology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Mark A KayDepartment of Genetics, Stanford University, Stanford, CA 94305, USA; Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Aaron D GitlerDepartment of Genetics, Stanford University, Stanford, CA 94305, USA.
Nicolas DupreNeuroscience Axis, CHU de Québec-Université Laval & Department of Medicine, Université Laval, Quebec City, QC G1J 1Z4, Canada.
Evan E EichlerDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Patrick A DionMontreal Neurological Institute and Hospital, McGill University, Montreal, QC H3A 2B4, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 2B4, Canada.
Guy A RouleauMontreal Neurological Institute and Hospital, McGill University, Montreal, QC H3A 2B4, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 2B4, Canada.
Paul N ValdmanisDivision of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: paulnv@uw.edu.
University of Washington Medical Center · USMontreal Neurological Institute and Hospital · CAStanford University · USUniversity of Washington · USMcGill University · CAVA Puget Sound Health Care System · USUniversité Laval · CA

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITEU24AG041689 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LI-SAN WANG · 2012 to 2026
$42.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Medical Genetics Training GrantT32GM007454 · NIGMS · UNIVERSITY OF WASHINGTON · PI Gail Pairitz Jarvik, Andrew Ben Stergachis · 1985 to 2026
$6.9M
Sequence-resolved structural variation of human genomesR01HG010169 · NHGRI · UNIVERSITY OF WASHINGTON · PI Evan Eichler · 2018 to 2026
$4.5M
Studies on RNAi Based Delivery in VivoR01DK078424 · NIDDK · STANFORD UNIVERSITY · PI KAY, MARK A · 2006 to 2014
$4.1M
NHGRI NIH HHS R01 HG010169NIA NIH HHS P30 AG066509NIA NIH HHS P50 AG005136NIA NIH HHS U24 AG041689NIDDK NIH HHS R01 DK078424NIGMS NIH HHS T32 GM007454
6 · The paper itself

Abstract

Tandem repeats are proposed to contribute to human-specific traits, and more than 40 tandem repeat expansions are known to cause neurological disease. Here, we characterize a human-specific 69 bp variable number tandem repeat (VNTR) in the last intron of WDR7, which exhibits striking variability in both copy number and nucleotide composition, as revealed by long-read sequencing. In addition, greater repeat copy number is significantly enriched in three independent cohorts of individuals with sporadic amyotrophic lateral sclerosis (ALS). Each unit of the repeat forms a stem-loop structure with the potential to produce microRNAs, and the repeat RNA can aggregate when expressed in cells. We leveraged its remarkable sequence variability to align the repeat in 288 samples and uncover its mechanism of expansion. We found that the repeat expands in the 3'-5' direction, in groups of repeat units divisible by two. The expansion patterns we observed were consistent with duplication events, and a replication error called template switching. We also observed that the VNTR is expanded in both Denisovan and Neanderthal genomes but is fixed at one copy or fewer in non-human primates. Evaluating the repeat in 1000 Genomes Project samples reveals that some repeat segments are solely present or absent in certain geographic populations. The large size of the repeat unit in this VNTR, along with our multiplexed sequencing strategy, provides an unprecedented opportunity to study mechanisms of repeat expansion, and a framework for evaluating the roles of VNTRs in human evolution and disease.

Indexed as

Evolution, MolecularAdaptor Proteins, Signal TransducingAgedAlzheimer DiseaseAmyotrophic Lateral SclerosisDNA Repeat ExpansionFemaleGene Expression RegulationHumansMaleMinisatellite RepeatsPhenotypeSpecies SpecificityTandem Repeat SequencesAdaptor Proteins, Signal TransducingWDR7 protein, humanamyotrophic lateral sclerosis, ALSancient genomesevolutionary geneticslong-read sequencingmodifier geneneurodegenerative diseasenoncoding RNAtandem repeat expansionvariable number tandem repeat, VNTRWD repeat domain 7, WDR7

Identifiers

PMID32750315
PMCPMC7477013
OpenAlexW3046227349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.